NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

NCT02184416

CompletedN/A

Sponsor: Pfizer

Conditions: Metastatic Renal Cell Carcinoma (mRCC)

Interventions: observational

Countries: Austria, Belgium, France, Greece, Italy, Netherlands, Spain, United Kingdom

This is an international, multi-centre, prospective (partly retrospective), observational study to evaluate treatment patterns and clinical outcomes in patients with advanced or metastatic RCC treated with sunitinib in first line and/or receiving axitinib in second line post sunitinib. The study is designed to enroll approximately 750 patients over the course of an enrollment period of approximately 36 months.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patient 18 years of age and over
* Histologically confirmed diagnosis of advanced/metastatic renal carcinoma (clear cell RCC as well as non-clear cell RCC) with measurable disease according to RECIST 1.1
* Patients being treated with Sutent in 1st line according to the European therapeutic indication and/or being treated with Inlyta in 2nd line according to the European approved therapeutic indication (except post cytokines)
* Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.

Exclusion Criteria:

* Patients being treated with cytokines or any other treatment outside of Sutent in 1st line
* Patients receiving anti -tumor treatment beyond a second line
* Patients already under Sutent, already under Inlyta: enrolment must occur at the beginning of each line of treatment (before or at the first follow up visit at the latest)

Locations (110)

Bregenz, Austria
Linz, Austria
Linz, Austria
Oberwart, Austria
Salzburg, Austria
Vienna, Austria
Vienna, Austria
Vienna, Austria
Aalst, Belgium
Bonheiden, Belgium
Ghent, Belgium
Ghent, Belgium
Ottignies, Belgium
Nice, Alpes-maritimes, France
Agen, France
Angers, France
Auxerre, France
Avignon, France
Bayonne, France
Bordeaux, France
Bordeaux, France
Bordeaux, France
Bourg-en-Bresse, France
Cabestany, France
Carcassonne, France
Cergy-Pontoise, France
Chalon-sur-Saône, France
Clermont-Ferrand, France
Clermont-Ferrand, France
Clermont-Ferrand, France
+ 80 more on CT.gov